Á¦1ȸ Áß¾Ó´ëÇб³º´¿ø À¯¹æ¾Ï ¿¬¼ö°Á : 2022-10-23±³À°ÀÏÀÚ : 2022-10-23
±³À°Àå¼Ò : Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦
±³À°ÁÖÁ¦ :
Á¦1ȸ Áß¾Ó´ëÇб³º´¿ø À¯¹æ¾Ï ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : Áß¾Ó´ëÇб³º´¿ø
´ã´çÀÚ : À̾Ⱥ¹
¿¬¶ôó : 070-8691-1705
À̸ÞÀÏ :
ab-lee@cauhs.or.kr ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï 10¿ù16ÀϱîÁö
http://cau.kjcomm.co.kr/ ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 09:30~09:55 Quality control of mammography °í°æÈñ(Â÷ÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 09:55~10:20 Breast screening ultrasonography: automated vs conventional Á¤±Õ¼ø(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 10:20~10:45 Experience of stereotactic biopsy ·ùÁ¤±Ô(°æÈñÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 10:45~11:10 The proliferative lesions of breast ¹Î¼ö±â(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 11:10~11:35 Genetics in breast cancer (NGS) ¹Ú°æ¼±(°æÈñÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 13:00~13:25 Management of Intraductal lesion ¾È¼ÒÀº(ÀÌ·¹¹ÌÁî¿Ü°úÀÇ¿ø)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 13:25~13:50 À¯¹æŬ¸®´Ð¿¡¼ ±Þ¿© û±¸½Ã ÁÖÀÇÁ¡ ±èÁØÈ£(Á¶ÀºÀ¯¿Ü°úÀÇ¿ø)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 13:50~14:15 À¯¹æ¼ºÇüȯÀÚ¿¡¼ ÃÊÀ½ÆĽà ÁÖÀÇÁ¡ ±è¼¼¿µ(´õ¼ºÇü¿Ü°úÀÇ¿ø)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 14:50~15:15 Current management of metastatic HER-2 breast cancer À±º´¿ì(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 15:15~15:40 Axillary lymph node management for 1 or 2 node positive case in permanent pathology ±è¹Î±Õ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 15:40~16:05 Chemotherapy in elderly breast cancer patients À̾Ⱥ¹(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-23 Á߾Ӵ뱤¸íº´¿ø±èºÎ¼·È¦ 16:05~16:30 Management of lymphedema in breast cancer patients ÀÌÀ¯°æ(Áß¾ÆÀÇ´ë)